Tag: Mallinckrodt
Covidien offloads pharmaceuticals division
May 29, 2013HME News Staff
DUBLIN, Ireland - The board of directors at Covidien, a global provider of healthcare products, recently approved the spinoff of its pharmaceuticals business, Hazelwood, Mo.-based Mallinckrodt, according to a press release. Covidien will transfer the pharmaceuticals business to Mallinckrodt, which will operate as an independent, publicly traded company. For every eight ordinary shares of Covidien held, shareholders will receive one ordinary share of Mallinckrodt, the release noted. The move is expected...
Covidien, Mallinckrodt, Pharmaceuticals
Sponsored Stories
SOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office
By John Koch, COO and co-founder, MediStreams